Changqing Ma

Medicine & Life Sciences

1. Adenocarcinoma 100%
2. Turcot syndrome 95%
3. Neoplasms 80%
4. DNA Mismatch Repair 79%
5. Upper Gastrointestinal Tract 69%
6. Lower Gastrointestinal Tract 63%
7. Protein Deficiency 62%
8. Biopsy 51%
9. Stomach 48%
10. Stomach Neoplasms 42%
11. Mutation 42%
12. Immunohistochemistry 40%
13. Microsatellite Instability 40%
14. Prostatic Neoplasms 38%
15. Gastrointestinal Tract 38%
16. Colorectal Neoplasms 37%
17. Portal Hypertension 36%
18. Papillary Thyroid Cancer 34%
19. Thyroid Neoplasms 33%
20. Biomarkers 30%
21. Disease-Free Survival 28%
22. Polyps 26%
23. DNA Repair-Deficiency Disorders 25%
24. Hepatopulmonary Syndrome 25%
25. Liver 25%
26. Fibrosis 24%
27. Signet Ring Cell Carcinoma 23%
28. Genotype 23%
29. Pancreas 23%
30. Ligands 23%
31. Proton Pump Inhibitors 22%
32. Epithelial Cell Adhesion Molecule 22%
33. Survival 22%
34. olmesartan 21%
35. Mesenteric Veins 21%
36. Oligonucleotide Array Sequence Analysis 21%
37. taxane 21%
38. Philippines 21%
39. Inflammatory Bowel Diseases 20%
40. Neoadjuvant Therapy 20%
41. Papillomaviridae 20%
42. Enteritis 20%
43. Sorafenib 20%
44. Androgens 19%
45. Gastritis 19%
46. Gastrointestinal Stromal Tumors 19%
47. Venules 19%
48. Nucleosomes 19%
49. Rectal Neoplasms 18%
50. Graft vs Host Disease 18%